160 related articles for article (PubMed ID: 29221895)
1. Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.
Ortiz JR; Hickling J; Jones R; Donabedian A; Engelhardt OG; Katz JM; Madhi SA; Neuzil KM; Rimmelzwaan GF; Southern J; Spiro DJ; Hombach J
Vaccine; 2018 Feb; 36(7):932-938. PubMed ID: 29221895
[TBL] [Abstract][Full Text] [Related]
2. Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.
Cox NJ; Hickling J; Jones R; Rimmelzwaan GF; Lambert LC; Boslego J; Rudenko L; Yeolekar L; Robertson JS; Hombach J; Ortiz JR
Vaccine; 2015 Nov; 33(48):6503-10. PubMed ID: 26478203
[TBL] [Abstract][Full Text] [Related]
3. Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.
Neuzil KM; Bresee JS; de la Hoz F; Johansen K; Karron RA; Krishnan A; Madhi SA; Mangtani P; Spiro DJ; Ortiz JR;
Vaccine; 2017 Oct; 35(43):5734-5737. PubMed ID: 28893473
[TBL] [Abstract][Full Text] [Related]
4. Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013.
Girard MP; Tam JS; Pervikov Y; Katz JM
Vaccine; 2013 Aug; 31(37):3766-71. PubMed ID: 23810374
[TBL] [Abstract][Full Text] [Related]
5. Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
Innis BL; Berlanda Scorza F; Blum JS; Jain VK; Older Aguilar A; Post DJ; Roberts PC; Wairagkar N; White J; Bresee J
Vaccine; 2019 Aug; 37(35):4823-4829. PubMed ID: 31362819
[TBL] [Abstract][Full Text] [Related]
6. Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009.
Stephenson I; Hayden F; Osterhaus A; Howard W; Pervikov Y; Palkonyay L; Kieny MP
Vaccine; 2010 May; 28(23):3875-82. PubMed ID: 20398616
[TBL] [Abstract][Full Text] [Related]
7. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
[TBL] [Abstract][Full Text] [Related]
8. Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005.
Hampson AW; Osterhaus AD; Pervikov Y; Kieny MP
Vaccine; 2006 Jun; 24(23):4897-4900. PubMed ID: 16823947
[TBL] [Abstract][Full Text] [Related]
9. Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union.
Navarro-Torné A; Hanrahan F; Kerstiëns B; Aguar P; Matthiessen L
Emerg Infect Dis; 2019 Feb; 25(2):. PubMed ID: 30666948
[TBL] [Abstract][Full Text] [Related]
10. Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations.
Innis BL; Scorza FB; Blum JS; Jain VK; Aguilar AO; Post DJ; Roberts PC; Wairagkar N; White J; Bresee J
Vaccine; 2019 Aug; 37(35):4830-4834. PubMed ID: 31362820
[TBL] [Abstract][Full Text] [Related]
11. Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine.
Viboud C; Gostic K; Nelson MI; Price GE; Perofsky A; Sun K; Sequeira Trovão N; Cowling BJ; Epstein SL; Spiro DJ
PLoS Pathog; 2020 Sep; 16(9):e1008583. PubMed ID: 32970783
[TBL] [Abstract][Full Text] [Related]
12. Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010.
Haaheim LR; Katz JM
Influenza Other Respir Viruses; 2011 Jul; 5(4):288-95. PubMed ID: 21651740
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for seasonal and pandemic influenza.
Nichol KL; Treanor JJ
J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
[TBL] [Abstract][Full Text] [Related]
14. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
Rudenko L; Yeolekar L; Kiseleva I; Isakova-Sivak I
Vaccine; 2016 Oct; 34(45):5436-5441. PubMed ID: 27593158
[TBL] [Abstract][Full Text] [Related]
15. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
[TBL] [Abstract][Full Text] [Related]
16. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
Isakova-Sivak I; Rudenko L
Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
[TBL] [Abstract][Full Text] [Related]
17. Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009.
Hayden FG; Howard WA; Palkonyay L; Kieny MP
Vaccine; 2009 Jun; 27(31):4079-89. PubMed ID: 19406184
[TBL] [Abstract][Full Text] [Related]
18. Advances in the development of universal influenza vaccines.
Gilbert SC
Influenza Other Respir Viruses; 2013 Sep; 7(5):750-8. PubMed ID: 22998622
[TBL] [Abstract][Full Text] [Related]
19. Influenza virus hemagglutinin stalk-based antibodies and vaccines.
Krammer F; Palese P
Curr Opin Virol; 2013 Oct; 3(5):521-30. PubMed ID: 23978327
[TBL] [Abstract][Full Text] [Related]
20. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
Poland GA; Fleming DM; Treanor JJ; Maraskovsky E; Luke TC; Ball EM; Poland CM
Vaccine; 2013 Apr; 31 Suppl 1():A1-20. PubMed ID: 23587330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
